Vor Biopharma (VOR) Payables (2020 - 2026)
Vor Biopharma (VOR) reported Payables of $1.0 million for Q1 2026, down 72.05% year-over-year from $3.7 million in Q1 2025, and down 79.66% quarter-over-quarter from $5.1 million in Q4 2025.
Vor Biopharma (VOR) Payables (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Payables data on file, last reported at $1.0 million in Q1 2026.
- Payables for Q1 2026 came in at $1.0 million, down 72.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 72.05% YoY), and the FY2025 annual result was $5.1 million, up 240.66% from the prior year.
- Payables fell to $1.0 million in Q1 2026 per VOR's latest filing, from $5.1 million in the prior quarter.
- Over five years, Payables peaked at $5.1 million in Q4 2025 and troughed at $669000.0 in Q2 2025.
- A 5-year average of $1.8 million and a median of $1.3 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2025 and 2026: Payables surged 240.66% in 2025, then plunged 72.05% in 2026.
- A 5-year view of Payables shows it stood at $1.8 million in 2022, then plunged by 54.01% to $815000.0 in 2023, then soared by 84.66% to $1.5 million in 2024, then surged by 240.66% to $5.1 million in 2025, then sank by 79.66% to $1.0 million in 2026.
- Business Quant data shows VOR's Payables at $1.0 million in Q1 2026, $5.1 million in Q4 2025, and $885000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Vor Biopharma | 627.54 Mn | 627.54 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 5.13 Mn |
| Sep 30, 2025 | 885,000.00 |
| Jun 30, 2025 | 669,000.00 |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 815,000.00 |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 824,000.00 |
| Jun 30, 2022 | 1.27 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | 1.96 Mn |
| Jun 30, 2021 | 2.37 Mn |